Small Cap Wrap – Symphony Environmental Technologies, Crossword Cybersecurity, Scotgold Resources an
Dish Of The Day:
No Joiners Today
Off The Menu:
No Leavers Today
What’s Cooking In The IPO Kitchen?
AIM Schedule One from Fonix, a mobile payments and messaging company, enabling businesses to charge users’ mobile bills and send users SMSs via their Carrier. Due October. Offer TBC
China Yangtze Power Co, intended secondary GDR offer on the LSE (standard listing) from the largest hydropower company in the world. Due on or around 30 September
Kaspi.kz, which operates the Kaspi.kz Super App, Kazakhstan’s most popular mobile app and the gateway to its market leading Payments, Marketplace and Fintech platforms intends to conduct a secondary GDR offer on the LSE.
Trupatti Graphite, the fully-integrated, cash generative, specialist graphite and graphene producer with operations in Madagascar and India, announced its potential intention to undertake an initial public offering on the LSE (standard listing).
Buffetology Smaller Companies Investment Trust– Buffettology is seeking to raise a minimum of GBP100 million via an initial placing, an offer for subscription and an intermediaries offer on the Main Market. will be the Investment Manager to the Company, led by Keith Ashworth-Lord (CIO of Sanford Deland Asset Management Limited). Sanford DeLand manages approximately GBP1.4 billion across two open ended funds, the CFP SDL UK Buffettology Fund and the Free Spirit(R) Fund.
AB Ignitis grupe–leading utility and renewable energy company in the Baltic region. Admission of its Shares to the Main Trading List of Nasdaq Vilnius and admission of its GDRs to the Official List of the FCA. Offer Price Range corresponds to a market capitalisation of approximately EUR1,691.7 – EUR2,105.2 million. Due 7 Oct.
Calnex, an established provider of test and measurement solutions for the global telecommunications sector, will raise a total of GBP22.5 million (before expenses), comprising GBP6.0 million for the Company and GBP16.5 million for existing shareholders . Due 5 October 2020, under the ticker CLX. Based on the Placing Price, the market capitalisation of the Company will be GBP42.0 million on Admission.
Mode Global Holdings to join LSE (standard). Mode is a UK-based Fintech Group, building a modern financial services business to support an increasingly digitised economy and financial system, combining the best of banking, payments, investment, loyalty and digital assets. Targeting GBP7.5m raise.
Guild Esports a UK-based owner and developer of esports teams, has announced its intention to seek a listing of its ordinary shares to the Standard Listing segment of the London Stock Exchange this autumn. its founding shareholders include David Beckham, former football player and captain of England, and now co-owner of new MLS team Inter Miami CF.
HOME REIT intends to float to the Main Market raising up to GBP250m. The Company will seek to contribute to the alleviation of homelessness in the UK, whilst targeting inflation-protected income and capital returns, by investing in a diversified portfolio of assets across the UK which will be dedicated to providing accommodation to the homeless. Due Mid October
Sativa Wellness Group–(Canadian Securities Exchange: STIL) renamed from Stillcanna Inc following the conditional acquisition of Sativa Group (AQSE:SATI) to list on the AQUIS Exchange. A fully integrated European seed to consumer CBD group with the pricing, products, and stability to meet the CBD market demand in the medium term. With world-class extraction and formulation experts, an agricultural team that has over 20 years’ experience farming hemp, along with laboratory testing capabilities, the group has established itself globally as a trusted source of high-grade, premium wholesale CBD brands and products.
Umuthi Healthcare Solutions Plc, the technology led healthcare business focused on the distribution of pharmaceuticals and the provision of medical facilities in remote areas, seeking admission to the Standard Listing segment of the Official List
Kibo Energy PLC, the multi-asset Africa focused energy company, is seeking admission for its 100% owned UK subsidiary Sloane Developments Ltd , which will be renamed Mast Energy Developments PLC (MED), to the Standard List of the London Stock Exchange plc . Targeted for Q4 2020. The MED business strategy is to acquire and develop a portfolio of flexible small-scale power generation assets, exploiting a growth niche market in the UK for Reserve Power generation to balance out the national grid at critical times.
Symphony Environmental Technologies* 28p GBP49.5m (LON:SYM)
The global specialist in technologies that “make plastics smarter” announced that AGS Airports Ltd (“AGS”), which operates Aberdeen, Glasgow and Southampton airports has become the first UK company to trial a new oxo-biodegradable 100 ml security bag.
The switch to oxo-biodegradable security bags is the latest initiative introduced to help reduce AGS’s carbon footprint. AGS has joined over 200 airports across Europe in signing ACI Europe’s NetZero 2050 pledge, a commitment to achieving net zero for the carbon under their control by 2050.
At a UK level, AGS is a signatory to Sustainable Aviation’s decarbonisation roadmap, which is the first national net zero aviation commitment anywhere in the world. Symphony’s oxo-biodegradable plastic bags have been introduced in partnership with Enviro-point, a subsidiary of airport service company Luggage-point.
Plastic bags and packaging made with Symphony’s d2w are just as strong, waterproof and flexible as regular plastic and can be used for all the same intents and purposes.
However, unlike regular plastic, d2w security bags do not create persistent microplastics, and if they escape collection and end up in the open environment as litter, the d2w will accelerate the natural process of oxidation.
Crossword Cybersecurity* 265p GBP13.6m (LON:CCS)
The technology commercialisation company focused solely on cyber security and risk, announced its unaudited interim results for the 6 months ended 30 June 2020.
Total revenue increased by 18% to GBP674,008. . Orders received for Rizikon Assurance during the period were 41% higher than those received in the same period last year.
The number of Rizikon opportunities continued to grow in the period.
Product and Consulting revenue increased by 43% over the same period in the prior year. . Consulting recurring revenue more than doubled over the same period in the prior year.
Total comprehensive loss for the period was GBP1,393,193, an increase of GBP315,598 over the same period in the prior year. . Cash and Cash Equivalents at 30 June 2020 was GBP1,550,317.
Continuing to convert pipeline into revenue, the Board is confident of achieving at least 25% revenue growth over 2019, for the year as a whole, and a loss before tax in line with current market expectations. Product and Consulting revenue is expected to growth by at least 35% over 2019. Crossword is dependent on the outcome of several large bids, including 2 multi-million pound opportunities, that are currently in progress, to deliver on market expectations for revenue for the full year. We therefore feel it prudent not to issue more detailed forward guidance until more clarity arises.
Scotgold Resources 122.5p GBP62.9m (LON:SGZ)
Grampian Project Exploration Update
Encouraging results of ongoing exploration programme focused on: o increasing the resource inventory at the Cononish Gold and Silver Mine, where first gold is expected by 30 November 2020; o further delineating existing prospects; and o making new discoveries
Cononish mine – identification of gold and silver anomalies to the north east of the mine that are consistent with the ‘Mother Vein’ structure
Beinn Udlaidh prospect – anomalous area highlighted as part of sampling programme focused on delineating multiple open-ended anomalies – highest Au value returned from current sampling is 15.15 parts per billion (“ppb”)
Inverchorachan prospect – multiple discrete anomalies identified with encouraging values of 22 ppb Au and 44 ppb Ag returned to date
Proton Motor Power 52.5p GBP384m (LON:PPS)
The designer, developer and producer of fuel cells and fuel cell electric hybrid systems with a zero-carbon footprint, announces that, following the order received in December 2019, it has received a further order from Fincantieri, one of the world’s largest shipbuilding groups, to deliver a fuel cell system with 144 kW fuel cell power to be installed into Fincantieri’s first 25 m long demonstrator and testing vessel, called “Zeus”, which will be exclusively powered by Proton Motor’s fuel cell system. Dr. Nahab, CEO of Proton, commented: “This is excellent news, with Proton having been the world’s first fuel cell system provider that has powered a ferry in Hamburg for 6 years between 2009 and 2014 with a 50 kW fuel cell system, it is a great achievement to receive a follow up order from Fincantieri at the ship building stage.”
GetBusy 77.5p GBP38.3m (LON:GETB)
The developer of document management and task management software, updated on trading. In addition, it confirms that, further to the announcement within the half-year results on 23 July 2020, it has signed a GBP2 million loan facility with Silicon Valley Bank The Group’s performance has remained robust since the half-year.
SmartVault’s annual contract value from new customers remains around 40% ahead of last year. We have started the investments announced in July in SmartVault product capabilities and growth to drive sustained increase in shareholder value over the coming years.
New business for Virtual Cabinet has also recovered and we are delighted to have secured an order from another Top 10 UK accounting firm.
The customer base for GetBusy continues to grow, albeit still at modest levels, and product functionality has further improved, including the launch of our inbuilt digital signature solution, which has the potential to provide significant opportunity in this rapidly growing market.
We continue to look to the future with confidence.
ValiRx 47p.5 GBP27.8m (LON:VAL)
Headline results from the recently completed Phase 1/2 clinical trial of its lead asset VAL201, for the treatment of advanced prostate cancer, held at University College Hospital (UCLH), London. Disease Impact – Overall Response Rate 54.5% . Of the 12 patients dosed with VAL201, 11 patients had sufficient PCWG2-relevant data collected across multiple cycles. 6 of these 11 have been categorised as responding throughout treatment. That is, when the treatment with VAL201 was halted for a defined reason, whether or not the 6 standard cycles had been completed, these patients showed no disease progression by PCWG2 criteria with stable disease.
The headline safety and tolerability results demonstrated only one dose-limiting toxicity event occurred. This was at a maximum dose of 8 mg/kg, with the patient having raised blood pressure (severe hypertension). Following treatment for the raised blood pressure, the patient completed the remainder of the trial.
A Maximum Tolerated Dose has not been determined for VAL201, and all doses remain available for further testing. No deaths were reported in patients during the clinical trial.
Christie Group 76.5p GBP20.3m (LON:CTG)
AGM Statement from the provider of Professional & Financial Services and Stock & Inventory Systems & Services to the hospitality, leisure, healthcare, medical, childcare & education “We enjoyed a successful 2019. Following a good start to the current year, we were affected by the onset of the Covid-19 pandemic and subsequent lockdown. Across the Group, in aggregate, approximately 50% of our expected revenue was lost from our first half. This represents an entire quarter’s income. Your management moved expeditiously to reduce costs, to avail ourselves of furlough grants and similar international governments’ assistance and take on a CLBILS loan of GBP6 million. We are now reviewing the Chancellor’s recently announced Job Support Scheme to identify whether that can provide further assistance. As soon as permitted we reopened our closed operations and have reintroduced staff progressively, as demand for our services increased. We have taken the opportunity, where desired, to reorganise our trading businesses. In each case seeking to maximise our on-line presence.
Incanthera 14.5p GBP8.8m (AQSE:INC)
The specialist oncology company focused on transforming cancer treatment, has received positive data from a skin sensitisation study of its skin cancer technology Sol. The study, conducted by XCellR8 Ltd, has demonstrated that our Sol formulation was found to be “non-irritant” using ex-vivo human skin.
Agreement with Canada-based biotech company Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) under which the parties will form STEM Animal Health Inc. (“STEM”), a company dedicated to treating biofilm-related ailments in animals.
The agreement will see Animalcare commercialise Kane Biotech’s range of oral care products for companion animals in European and Asian markets and collaborate on the development of new biofilm treatments for animals.
Serinus Energy 5.5p GBP13.2m (LON:SENX)
Serinus Energy has received a formal waiver from the European Development and Reconstruction Bank (“EBRD”) in relation to the debt service covenant on its Convertible Loan for the period ending 30 September 2020.
0203 764 2344